CALIFORNIA | LOCAL
July 1, 1991 |
Researchers last week reported progress in finding ways to administer insulin through pills, drinks or nasal spray to help diabetics control their blood-sugar levels more easily and take fewer shots. While freedom from shots is still thought to be a long way off, researchers on separate projects in Israel, France and England said the experimental insulin treatments may mimic the body's functions more closely than injections.
November 19, 1986 |
Doctors at Johns Hopkins Hospital announced Tuesday the first successful implant of a new insulin pump, a device they say could help the 1 million insulin-dependent diabetics in the United States. Physicians said Jackson Piotrow, of Bethesda, Md., received the pump last week during a 45-minute operation and appears to be doing well with the device.
June 11, 1995 |
Preliminary studies indicate that giving doses of insulin can delay the development of insulin-dependent diabetes in people who are at high risk of the disease, researchers said Saturday. A large-scale study is under way to determine how often and for how long insulin can delay the onset of Type I diabetes, which occurs most often in children and young adults. The disease affects the metabolism of sugars and can cause such complications as blindness and kidney failure.
CALIFORNIA | LOCAL
October 24, 1996 |
The first clinical trial of a surgically implanted insulin pump in Type 2 diabetics has shown that it is just as effective at controlling blood sugar levels as multiple daily injections, but that freedom from injections produces a better quality of life. The study, reported in the Oct. 23 Journal of the American Medical Assn., was conducted on 105 men, ages 40 to 69, at seven VA medical centers.
January 28, 2006 |
Federal regulators Friday approved the first inhaled insulin treatment, offering millions of diabetics a chance to ease the grueling ritual of repeated daily injections. Called Exubera, the drug allows patients to control their blood-sugar levels by inhaling a fine insulin powder through a flashlight-size device. The drug, to be marketed by Pfizer Inc., could reduce or eliminate the need for before-meal insulin shots.
CALIFORNIA | LOCAL
September 13, 1985 |
Dave Stenger, a laboratory assistant at UC Irvine, is 37 years old and has been a diabetic for 32 of those years. Six years ago, Stenger began using an insulin pump to supply him with the insulin he needs to stabilize the level of glucose in his blood. Four years earlier, he had lost vision in one of his eyes as a result of his diabetes.
June 27, 1992 |
Diabetics may soon receive long-lasting insulin implants, freeing them from daily insulin injections, researchers at Harvard Medical School said. Dr. Robert Lanza said dogs have been successfully implanted with a kind of artificial pancreas which holds capsules that release insulin-producing cells. The technology will be tested on humans within a year, he said. While not a cure for diabetes, Lanza said it could become the preferred treatment.
March 1, 2004 |
Giving insulin along with clot-busting medications and other drugs after a heart attack may improve the likelihood of survival by limiting inflammation and damage to the heart muscle. In a study of 32 heart attack patients treated in the emergency room at the University of Buffalo, researchers gave half the participants a low-dose infusion of insulin for 48 hours in addition to the clot-buster reteplase and other common heart attack treatments, including aspirin and the blood thinner heparin.
June 17, 1998 |
The first clinical trials using an inhaled form of insulin to treat diabetics have proved highly successful, paving the way for a greatly reduced reliance on painful and inconvenient injections of the life-saving hormone, scientists reported Tuesday. The key to the study is the development of a finely powdered form of insulin that is sucked through the mouth into the lungs, where it is rapidly absorbed into the bloodstream to control blood sugar levels.
February 8, 1990 |
The regents of the University of California on Wednesday sued Eli Lilly & Co., alleging that the largest U.S. maker of insulin infringed on a university patent for the biotechnology that Lilly uses to make its genetically engineered insulin product. The university obtained the patent in 1984 after the technology was developed by four scientists at UC San Francisco, the regents said in a complaint filed in U.S. District Court in San Francisco.